Search - tctmd.com

Displaying 281 - 300 of 386

Sort: Relevancy | Date

News Industry News

St. Jude Medical Gains CE Mark for 27mm & 29mm Portico TAVR Valves to Complete a Full Portfolio of Portico Sizing Options for Physicians Treating Patients with Aortic Stenosis

September 18, 2015

News Features

Same-Day TAVR: Anomaly or Wave of the Future?

L.A. McKeown

August 27, 2015

News Daily News

慢性起搏与球囊扩张TAVR术后的较低存活率有联系

August 20, 2015

News Daily News

Los Marcapasos Crónicos se asocian a una Menor Supervivencia Post-TAVR con Balón Expandible

August 20, 2015

News Daily News

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

August 20, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Daily News

Study Explores Safety of Early Discharge After Transfemoral TAVR

L.A. McKeown

June 24, 2015

News Daily News

La FDA Aprueba 2 Nuevos Sistemas TAVR para Pacientes de Alto Riesgo e Inoperable

Yael L. Maxwell

June 24, 2015

News Daily News

FDA 批准 2 项新 TAVR 系统用于治疗高危、无法手术的患者

Yael L. Maxwell

June 24, 2015

News Daily News

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Yael L. Maxwell

June 24, 2015

News Daily News

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

Todd Neale

June 18, 2015

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

Presentation TVT 2015

Case Presentation: High Risk for Pacemaker With LV Dysfunction and TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Hemal Gada

June 05, 2015

Advertisement

St. Jude Medical Gains CE Mark for 27mm & 29mm Portico TAVR Valves to Complete a Full Portfolio of Portico Sizing Options for Physicians Treating Patients with Aortic Stenosis

Same-Day TAVR: Anomaly or Wave of the Future?

慢性起搏与球囊扩张TAVR术后的较低存活率有联系

Los Marcapasos Crónicos se asocian a una Menor Supervivencia Post-TAVR con Balón Expandible

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

Study Explores Safety of Early Discharge After Transfemoral TAVR

La FDA Aprueba 2 Nuevos Sistemas TAVR para Pacientes de Alto Riesgo e Inoperable

FDA 批准 2 项新 TAVR 系统用于治疗高危、无法手术的患者

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

Case Presentation: High Risk for Pacemaker With LV Dysfunction and TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content